Kraig Biocraft Laboratories (KBLB) 10-Q 6 May 22 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2022	May 06, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2022
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	333-146316
Entity Registrant Name	KRAIG BIOCRAFT LABORATORIES, INC.
Entity Central Index Key	0001413119
Entity Tax Identification Number	83-0459707
Entity Incorporation, State or Country Code	WY
Entity Address, Address Line One	2723 South State St. Suite 150
Entity Address, City or Town	Ann Arbor
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48104
City Area Code	(734)
Local Phone Number	619-8066
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		957,535,841

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets
Cash	$ 3,930,605	$ 2,355,060
Prepaid expenses	3,951	11,055
Total Current Assets	3,934,556	2,366,115
Property and Equipment, net	103,493	110,943
Investment in gold bullions (cost $450,216 and $450,216, respectively)	460,163	437,212
Operating lease right-of-use asset, net	93,132	104,124
Security deposit	3,518	3,518
Total Assets	4,594,862	3,021,912
Current Liabilities
Accounts payable and accrued expenses	563,086	587,794
Note payable - related party	1,617,000	1,657,000
Royalty agreement payable - related party	65,292	65,292
Accounts payable and accrued expenses - related party	5,356,417	5,244,560
Operating lease liability, current	46,178	44,577
Loan payable	72,622	60,000
Convertible note payable, net of debt discount of $634,548 and $246,577, respectively	865,452	503,423
Total Current Liabilities	8,586,047	8,162,646
Long Term Liabilities
Loan payable, net of current	62,622	95,244
Operating lease liability, net of current	47,653	59,897
Total Liabilities	8,696,322	8,317,787
Commitments and Contingencies (Note 9)
Stockholders’ Deficit
Preferred stock Series A, no par value; 2 and 2 shares issued and outstanding, respectively
Common Stock Issuable, 1,122,311 and 1,122,311 shares, respectively	22,000	22,000
Additional paid-in capital	10,599,108	9,894,179
Accumulated Deficit	(43,861,665)	(42,814,986)
Total Stockholders’ Deficit	(4,101,460)	(5,295,875)
Total Liabilities and Stockholders’ Deficit	4,594,862	3,021,912
Series A Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock Series A, no par value; 2 and 2 shares issued and outstanding, respectively	5,217,800	5,217,800
Common Class A [Member]
Stockholders’ Deficit
Common stock Class B, no par value; unlimited shares authorized, no shares issued and outstanding	23,921,297	22,385,132
Common Class B [Member]
Stockholders’ Deficit
Common stock Class B, no par value; unlimited shares authorized, no shares issued and outstanding

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Investment Owned, at Cost	$ 450,216	$ 450,216
Debt discount, net	$ 634,548	$ 246,577
Preferred stock, no par value	$ 0	$ 0
Preferred stock, shares authorized	Unlimited	Unlimited
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock issuable	1,122,311	1,122,311
Series A Preferred Stock [Member]
Preferred stock, no par value	$ 0	$ 0
Preferred stock, shares issued	2	2
Preferred stock, shares outstanding	2	2
Common Class A [Member]
Common stock, no par value	$ 0	$ 0
Common stock, shares authorized	Unlimited	Unlimited
Common stock, shares issued	950,905,044	927,378,166
Common stock, shares outstanding	950,905,044	927,378,166
Common Class B [Member]
Common stock, no par value	$ 0	$ 0
Common stock, shares authorized	Unlimited	Unlimited
Common stock, shares issued	0	0
Common stock, shares outstanding	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenue
Operating Expenses
General and Administrative	213,019	306,587
Professional Fees	120,380	107,485
Officer’s Salary	184,808	159,898
Rent - Related Party		3,273
Research and Development	27,504	87,768
Total Operating Expenses	545,711	665,011
Loss from Operations	(545,711)	(665,011)
Other Income/(Expenses)
Gain on debt extinguishment (PPP)		90,100
Net change in unrealized appreciation on investment in gold bullion	22,951
Interest expense	(161,887)	(130,259)
Amortization of debt issue costs	(362,032)	(235,492)
Total Other Income/(Expenses)	(500,968)	(275,651)
Net (Loss) before Provision for Income Taxes	(1,046,679)	(940,662)
Provision for Income Taxes
Net (Loss)	$ (1,046,679)	$ (940,662)
Net Income (Loss) Per Share - Basic and Diluted	$ 0	$ 0
Weighted average number of shares outstanding during the period - Basic and Diluted	939,450,295	855,136,759

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Changes in Stockholders Deficit (Unaudited) - USD ($)	Series A Preferred Stock [Member]Preferred Stock [Member]	Common Class A Stock [Member]Common Stock [Member]	Common Class BStock[Member]Common Stock [Member]	Common stock classA shares to be issued [Member]Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 5,217,800	$ 17,122,236		$ 22,000	$ 5,833,583	$ (34,769,183)	$ (6,573,564)
Balance, shares at Dec. 31, 2020	2	854,410,001		1,122,311
Warrants issued for services - related parties					105,095		105,095
Warrants issued for services					15,858		15,858
Imputed interest - related party					20,429		20,429
Beneficial conversion feature					450,000		450,000
Net loss						(940,662)	(940,662)
Cancellations of warrants					(42,707)		(42,707)
Exercise of warrants in exchange for stock		$ 381,317			(292,533)		88,784
Exercise of warrants in exchange for stock, shares		2,336,794
Ending balance, value at Mar. 31, 2021	$ 5,217,800	$ 17,503,553		$ 22,000	6,089,725	(35,709,845)	(6,876,767)
Balance, shares at Mar. 31, 2021	2	856,746,795		1,122,311
Beginning balance, value at Dec. 31, 2021	$ 5,217,800	$ 22,385,132		$ 22,000	9,894,179	(42,814,986)	(5,295,875)
Balance, shares at Dec. 31, 2021	2	927,378,166		1,122,311
Warrants issued for services - related parties					53,699		53,699
Warrants issued for services					7,842		7,842
Exercise of warrants in exchange for cash		$ 739,864					739,864
Exercise of warrants in exchange for cash, shares		11,097,959
Convertible debt and accrued interest conversion into common stock ($0.06/Sh)		$ 796,301					796,301
Convertible debt conversion into common stock, shares		12,428,919
Imputed interest - related party					18,385		18,385
Beneficial conversion feature					625,003		625,003
Net loss						(1,046,679)	(1,046,679)
Ending balance, value at Mar. 31, 2022	$ 5,217,800	$ 23,921,297		$ 22,000	$ 10,599,108	$ (43,861,665)	$ (4,101,460)
Balance, shares at Mar. 31, 2022	2	950,905,044		1,122,311

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Changes in Stockholders Deficit (Unaudited) (Parenthetical) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Warrant exercise price per share	$ 0.06
Warrant exercise price per share	0.08
Conversion price per share	0.06
Warrant [Member]
Warrant exercise price per share	$ 0.001	$ 0.001
Issuance of warrant exercise		2,336,794

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows From Operating Activities:
Net Loss	$ (1,046,679)	$ (940,662)
Adjustments to reconcile net loss to net cash used in operations
Depreciation expense	7,450	6,668
Gain on debt extinguishment (PPP)		(90,100)
Net change in unrealized appreciation in gold bullions	(22,951)
Amortization of debt discount	362,032	235,492
Imputed interest - related party	18,385	20,429
Warrants issued to consultants	61,541	78,246
Changes in operating assets and liabilities:
Decrease in prepaid expenses	7,104	443
Operating lease right-of-use, net	10,992	40,928
Increase in accrued expenses and other payables - related party	111,857	224,464
Increase in accounts payable	21,593	45,640
Operating lease liabilities, current	(10,643)	(40,201)
Net Cash Used In Operating Activities	(479,319)	(418,653)
Net Cash Used In Investing Activities
Cash Flows From Financing Activities:
Repayment of notes payable - related party	(40,000)
Proceeds from convertible note payable, net of original issue discount	1,490,000	450,000
Payment of debt offering costs	(115,000)
Principal payments on debt	(20,000)	(10,000)
Proceeds from warrant exercise	739,864	88,784
Net Cash Provided by Financing Activities	2,054,864	528,784
Net Increase in Cash	1,575,545	110,131
Cash at Beginning of Period	2,355,060	816,907
Cash at End of Period	3,930,605	927,038
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:
Shares issued in connection with cashless warrants exercise		381,317
Debt Discount in connection with convertible debt	625,003	450,000
Shares issued in connection with convertible note payable	$ 796,301

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION	NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (A) Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in The United States of America and the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations. It is management’s opinion, however that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. On March 5, 2018, the Company issued a board resolution authorizing investment in a Vietnamese subsidiary and appointing a representative for the subsidiary. On April 24, 2018, the Company announced that it had received its investment registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. On May 1, 2018, the Company announced that it had received its enterprise registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd Foreign Currency The assets and liabilities of Prodigy Textiles, Co., Ltd. (the Company’s Vietnamese subsidiary) whose functional currency is the Vietnamese Dong, are translated into US dollars at period-end exchange rates prior to consolidation. Income and expense items are translated at the average rates of exchange prevailing during the period. The adjustments resulting from translating the Company’s financial statements are reflected as a component of other comprehensive (loss) income. Foreign currency transaction gains and losses are recognized in net earnings based on differences between foreign exchange rates on the transaction date and settlement date. Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Cash For the purposes of the cash flow statements, the Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. There were no Loss Per Share Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by the Financial Accounting Standards Board (“FASB” Accounting Standards Codification (“ASC”) No. 260, “Earnings per Share.” For March 31, 2022 and December 31, 2021, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive. The computation of basic and diluted loss per share for March 31, 2022 and 2021 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE March 31, 2022 December 31, 2021 Stock Warrants 54,660,034 48,972,277 Stock Warrants (Exercise price - $ 0.001 0.25 54,660,034 48,972,277 Stock Options (Exercise price - $ 0.1150 26,802,500 26,802,500 Convertible Debt 22,507,890 6,470,674 Convertible Preferred Stock 2 2 Total 103,970,426 82,245,453 Research and Development Costs The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation. Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC No. 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC No. 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Stock-Based Compensation The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (“ASC 718”). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee’s requisite service period (generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed consolidated statements of operations. The Company accounts for stock-based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07. Recent Accounting Pronouncements Changes to accounting principles are established by the FASB in the form of ASU’s to the FASB’s Codification. We consider the applicability and impact of all ASU’s on our financial position, results of operations, stockholders’ deficit, cash flows, or presentation thereof. Management has evaluated all recent accounting pronouncements as issued by the FASB in the form of Accounting Standards Updates (“ASU”) through the date these financial statements were available to be issued and found no recent accounting pronouncements issued, but not yet effective accounting pronouncements, when adopted, will have a material impact on the financial statements of the Company. In September 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Measurement of Credit Losses on Financial Instruments, which supersedes current guidance by requiring recognition of credit losses when it is probable that a loss has been incurred. The new standard requires the establishment of an allowance for estimated credit losses on financial assets including trade and other receivables at each reporting date. The new standard will result in earlier recognition of allowances for losses on trade and other receivables and other contractual rights to receive cash. In November 2019, the FASB issued ASU No. 2019-10, Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842), which extends the effective date of Topic 326 for certain companies until fiscal years beginning after December 15, 2022. The new standard will be effective for the Company in the first quarter of fiscal year beginning January 1, 2023, and early adoption is permitted. We adopted this pronouncement on January 1, 2021; however, the adoption of this standard did not have a material effect on the Company’s financial statements. In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes.” This guidance, among other provisions, eliminates certain exceptions to existing guidance related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also requires an entity to reflect the effect of an enacted change in tax laws or rates in its effective income tax rate in the first interim period that includes the enactment date of the new legislation, aligning the timing of recognition of the effects from enacted tax law changes on the effective income tax rate with the effects on deferred income tax assets and liabilities. Under existing guidance, an entity recognizes the effects of the enacted tax law change on the effective income tax rate in the period that includes the effective date of the tax law. ASU 2019-12 is effective for interim and annual periods beginning after December 15, 2020, with early adoption permitted. We adopted this pronouncement on January 1, 2021; however, the adoption of this standard did not have a material effect on the Company’s financial statements. However, based on the Company’s history of immaterial credit losses from trade receivables, management does not expect that the adoption of this standard will have a material effect on the Company’s financial statements. In August 2020, FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”), as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component, unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium. As a result, after adopting the guidance, entities will no longer separately present such embedded conversion features in equity and will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current accounting treatment under the current guidance. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the fiscal year. The Company adopted the guidance under ASU 2020-06 on January 1, 2022. The adoption of this guidance and had no material impact on the Company’s financial statements. Equipment The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. In accordance with FASB ASC No. 360, Property, Plant and Equipment, There were no Fair Value of Financial Instruments We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” The three levels of the fair value hierarchy under ASC Topic 820-10 are described below: ● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at March 31, 2022 and 2021. ● Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. ● Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms. SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS March 31, 2022 December 31, 2021 Level 1 – Investment in Gold $ 460,163 $ 437,212 Level 2 $ - $ - Level 3 $ - $ - Total $ 460,163 $ 437,212 The Board of Directors, who serves as the Custodian, is responsible for the safekeeping of gold bullion owned by the Company. Fair value of the gold bullion held by the Company is based on that day’s London Bullion Market Association (“LBMA”) Gold Price PM. “LBMA Gold Price PM” is the price per fine troy ounce of gold, stated in U.S. dollars, determined by ICE Benchmark Administration (“IBA”) following an electronic auction consisting of one or more 30-second rounds starting at 3:00 p.m. (London time), on each day that the London gold market is open for business and published shortly thereafter. The following tables summarize activity in gold bullion for the quarter ended March 31, 2022: SCHEDULE OF GOLD IN BULLION Quarter Ended March 31, 2022 Ounces Cost Fair Value Balance December 31, 2021 239 $ 1,884 $ 437,212 Net change in unrealized gain - - 22,951 Ending balance 239 $ 1,884 $ 460,163 Revenue Recognition Effective January 1, 2018, the Company adopted ASC No. 606 — Revenue from Contracts with Customers. Under ASC No. 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the three months ended March 31, 2022 and 2021, the Company recognized $ 0 0 Concentration of Credit Risk The Company at times has cash in banks in excess of FDIC insurance limits. At March 31, 2022 and December 31, 2021, the Company had approximately $ 3,362,681 2,092,420 Original Issue Discount For certain notes issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded as a debt discount, reducing the face amount of the note, and is amortized to amortization of original issue discount in the consolidated statements of operations over the life of the debt. Debt Issue Cost Debt issuance cost paid to lenders, or third parties are recorded as debt discounts and amortized to interest expense in the consolidated statements of operations, over the life of the underlying debt instrument.

GOING CONCERN

GOING CONCERN	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2 GOING CONCERN As reflected in the accompanying condensed unaudited financial statements, the Company has a working capital deficiency of $ 4,651,491 and stockholders’ deficiency of $ 4,101,460 and used $ 479,319 of cash in operations for the three months ended March 31, 2022. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management believes that actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.

EQUIPMENT

EQUIPMENT	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
EQUIPMENT	NOTE 3 EQUIPMENT At March 31, 2022 and December 31, 2021, property and equipment, net, is as follows: SCHEDULE OF PROPERTY AND EQUIPMENT March 31, 2022 December 31, 2021 Automobile $ 41,805 $ 41,805 Laboratory Equipment 118,890 118,890 Office Equipment 7,260 7,260 Leasehold Improvements 82,739 82,739 Property and equipment, gross Less: Accumulated Depreciation (147,201 ) (139,751 ) Total Property and Equipment, net $ 103,493 $ 110,943 Depreciation expense for the three months ended March 31, 2022 and 2021, was $ 7,450 6,668

RIGHT TO USE ASSETS AND LEASE L

RIGHT TO USE ASSETS AND LEASE LIABILITITY	3 Months Ended
	Mar. 31, 2022
Right To Use Assets And Lease Liabilitity
RIGHT TO USE ASSETS AND LEASE LIABILITITY	NOTE 4 - RIGHT TO USE ASSETS AND LEASE LIABILITITY Since September of 2015, we rent office space at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104, which is our principal place of business. We pay an annual rent of $ 2,508 On January 23, 2017 the Company signed an 8 year property lease with the Company’s President for land in Texas where the Company grows its mulberry. The Company pays a monthly rent of $ 960 0 3,683 44,419 On September 5, 2019, we signed a two-year 5,000 42,000 44,800 42,000 44,800 79,862 79,862 On May 9, 2019 the Company signed a 5 4,560.57 45,150 5 241,800 On July 1, 2021, the Company signed a 5 6,000 8,645 Right to use assets is summarized below: SCHEDULE OF RIGHT USE OF ASSETS March 31, 2022 Right to use assets, net 61,057 Right to use assets, net 32,074 Total $ 93,132 During the three months ended March 31, 2022, the Company recorded $ 13,638 Lease liability is summarized below: SCHEDULE OF LEASE LIABILITY March 31, 2022 Operating lease liability, net 61,757 Operating lease liability, net 32,074 Total 93,831 Less: short term portion (46,178 ) Long term position $ 47,653 Lease expense for the three months ended March 31, 2022 was comprised of the following: SCHEDULE OF LEASE COST Operating lease expense $ 11,477 Operating lease expense $ 2,161

ACCRUED INTEREST _ RELATED PART

ACCRUED INTEREST – RELATED PARTY	3 Months Ended
	Mar. 31, 2022
Accrued Interest Related Party
ACCRUED INTEREST – RELATED PARTY	NOTE 5 ACCRUED INTEREST – RELATED PARTY On June 6, 2016, the Company received a $ 50,000 30,000 100,000 15,000 20,000 15,000 15,000 20,000 26,000 11,000 20,000 3,000 30,000 30,000 20,000 20,000 17,000 100,000 100,000 100,000 100,000 100,000 100,000 150,000 100,000 100,000 100,000 30,000 30,000 35,000 70,000 3 On January 26, 2022, the Company repaid $ 40,000 Total loan payable to principal stockholder for as of March 31, 2022 is $ 1,617,000 Total loan payable to this principal stockholder as of December 31, 2021 is $ 1,657,000 During the three months ended March 31, 2022, the Company recorded $ 18,385 13,610 During the three months ended March 31, 2021, the Company recorded $ 20,429 13,283

NOTE PAYABLE

NOTE PAYABLE	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
NOTE PAYABLE	NOTE 6 NOTE PAYABLE On March 1, 2019, the Company entered into an unsecured promissory note with Notre Dame - an unrelated party in the amount of $ 265,244 10% 20,000 1. $ 1,000 2. $ 2,000 3. $ 5,000 4. Final payment of all remaining balance, in the amount of $ 180,224 On July 8, 2021, the Company entered into an amendment to the March 1, 2019 agreement. As of the date of the amendment, the remaining outstanding balance is $ 180,244 1. $ 5,000 2. Final payment of the remaining balance in the amount of $ 115,244 57,622 57,622

CONVERTIBLE NOTES

CONVERTIBLE NOTES	3 Months Ended
	Mar. 31, 2022
Convertible Notes
CONVERTIBLE NOTES	NOTE 7 CONVERTIBLE NOTES The Company issued a $ 1,000,000 10% 5% 50,000 950,000 The note contains a discount to market feature, whereby, the lender can purchase stock at 90% of the lowest trading price for a period of ten (10) days preceding the conversion date Additionally, the Company issued 3,125,000 5 2,599,066 SCHEDULE OF FAIR VALUE WARRANTS Stock Price $ 0.14 Exercise price $ 0.16 Expected term (in years) 5 Expected volatility 60.64 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.10 % The Company has determined that ASC 815 does not apply since the Company has unlimited authorized shares, which in turn satisfies the requirement of having sufficient authorized shares available to settle any potential instruments that may require physical net-share settlement. Pursuant to ASC 470, the Company will record a beneficial conversion feature (“BCF”) based upon the relative fair value of the conversion feature within the convertible note and the related warrants. The BCF cannot exceed the face amount of the note, therefore, the discount for this note is $ 1,000,000 The Company also paid $ 86,000 On March 25, 2021, the Company entered into one year, unsecured, convertible note in the aggregate principal amount of $ 4,000,000 500,000 March 25, 2022 10% The note contains a discount to market feature, whereby, the lender can purchase stock at 80% of the lowest trading price for a period of ten (10) days preceding the conversion date 500,000 3,000,000 Additionally, the Company issued 8,000,000 5 3,359,716 Stock Price $ 0.15 Exercise price $ 0.25 Expected term (in years) 5 Expected volatility 100.76 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.07 % The Company has determined that ASC 815 does not apply since the Company has unlimited authorized shares, which in turn satisfies the requirement of having sufficient authorized shares available to settle any potential instruments that may require physical net-share settlement. Pursuant to ASC 470, the Company will record a beneficial conversion feature (“BCF”) based upon the relative fair value of the conversion feature within the convertible note and the related warrants. The BCF cannot exceed the face amount of the note, therefore, the discount for this note is $ 3,670,000 The Company also paid $ 330,000 On January 21, 2022, the Company issued 3,935,417 shares of Common Stock in exchange for conversion of $ 250,000 of principle balance on a convertible debenture and $ 2,260 of accrued interest. Accordingly, no gain or loss was recognized upon debt conversion. On January 31, 2022, the Company issued 4,569,059 shares of Common Stock in exchange for conversion of $ 250,000 of principle balance on a convertible debenture and $ 42,877 of accrued interest. Accordingly, no gain or loss was recognized upon debt conversion. On February 16, 2022, the Company issued 3,924,443 shares of Common Stock in exchange for conversion of $ 250,000 of principle balance on a convertible debenture and $ 1,164 of accrued interest. Accordingly, no gain or loss was recognized upon debt conversion. As of March 31, 2022, the above two notes were fully converted, with the no remaining balance due. The Company issued a $ 1,500,000 10% 10,000 1,490,000 The note contains a discount to market feature, whereby, the lender can purchase stock at 85% of the lowest trading price for a period of ten (10) days preceding the conversion date Additionally, the Company issued 12,000,000 five-year ( 5 ) warrants with an exercise price of $ 0.12 per share, and 4,285,714 warrants with an exercise price of $ 0.14 per share during the three months ended March 31, 2022. The warrants had a fair value of $ 1,071,437 , based upon using a black-scholes option pricing model with the following inputs: Stock Price $ 0.08 Exercise price $ 0.12 Exercise price $ 0.14 Expected term (in years) 5 Expected volatility 124.10 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.58 % The Company has determined that ASC 815 does not apply since the Company has unlimited authorized shares, which in turn satisfies the requirement of having sufficient authorized shares available to settle any potential instruments that may require physical net-share settlement. In connection with $ 1,500,000 16,785,714 625,003 The Company also paid $ 115,000 The following represents a summary of the Company’s convertible debt at March 31, 2022: SUMMARY OF CONVERTIBLE DEBT Convertible Note Payable Amounts In-Default Balance – December 31, 2021 $ 503,423 $ Proceeds – net 1,500,000 - Debt discount and issue costs recorded (750,003 ) - Conversion of debt into common shares (750,000 ) Amortization of debt discount 362,032 - Balance – March 31, 2022 $ 865,452 $ - Accrued Interest Payable Amounts In-Default Balance – December 31, 2021 $ 31,657 $ Interest Expense March 31, 2022 45,180 - Interest conversion into common shares (46,301 ) Balance – March 31, 2022 $ 30,537 $ -

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 8 STOCKHOLDERS’ DEFICIT (A) Common Stock Issued for Cash On March 9, 2019, the Company entered into a purchase agreement with one investor (the “Purchase Agreement”). Pursuant to the Purchase Agreement, the Company issued the investor 14,797,278 0.06758 1,000,000 14,797,278 14,797,278 0.06 7,398,639 0.08 ● ½ of all $ 0.06 March 8, 2021 ● ½ of all $ 0.06 March 8, 2022 ● ½ of all $ 0.08 March 8, 2022 ● ½ of all $ 0.08 March 8, 2023 On March 2, 2021, the Company determined to amend and extend the expiration of the warrants expiring on March 8, 2021 as follows: ● 1,479,728 0.06 March 8, 2021 ● 1,479,728 0.06 May 8, 2021 ● 1,479,728 0.06 July 8, 2021 December 8, 2021 ● 1,479,728 0.06 September 8, 2021 ● 1,479,727 0.06 November 8, 2021 On February 15, 2022, the Company issued 7,398,639 7,398,639 443,918 On February 15, 2022, the Company issued 3,699,320 3,699,320 295,946 (B) Common Stock Warrants and Options On February 15, 2022, the Company issued 7,398,639 7,398,639 443,918 On February 15, 2022, the Company issued 3,699,320 3,699,320 295,946 On January 25, 2021, the Company issued a 7-year option to purchase 2,500,000 0.134 310,165 Options vest 33.3% on the year one anniversary of the grant date, 33.3% will vest on the second anniversary, and 33.3% will vest on the third year anniversary as long as the employee remains with the Company at the end of each successive year for three years 27,989 SCHEDULE OF OPTION ASSUMPTION Expected dividends 0 % Expected volatility 133.22 % Expected term 7 Risk free interest rate 1.46 % Expected forfeitures 0 % On February 19, 2020 the Company issued a 10-year option to purchase 6,000,000 0.115 626,047 Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030 25,710 Expected dividends 0 % Expected volatility 125.19 % Expected term 3 Risk free interest rate 1.50 % Expected forfeitures 0 % On February 19, 2020 the Company issued a 7-year option to purchase 1,340,000 shares of common stock at an exercise price of $ 0.115 per share to employees for services rendered. The options had a fair value of $ 133,063 , based upon the Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027 . During the three months ended March 31, 2022, the Company recorded $ 7,842 as an expense for options issued Expected dividends 0 % Expected volatility 125.19 % Expected term 6 Risk free interest rate 1.46 % Expected forfeitures 0 % SCHEDULE OF WARRANTS ACTIVITY Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in Years) Balance, December 31, 2021 48,972,279 - 2.64 Granted 16,785,714      - Exercised (11,097,959 ) - - Cancelled/Forfeited - - - Balance, March 31, 2022 54,660,032 - 3.63 Intrinsic Value $ 1,166,993 For the three months ended March 31, 2022, the following warrants were outstanding: SCHEDULE OF WARRANTS OUTSTANDING Exercise Price Warrants Weighted Average Aggregate $ 0.001 11,000,000 2.82 $ 981,000 $ 0.056 1,000,000 3.27 $ 34,000 $ 0.04 2,300,000 4.51 $ 115,000 $ 0.08 3,699,320 0.94 $ 36,993 $ 0.2299 8,250,000 2.96 $ - $ 0.16 3,125,000 3.70 $ - $ 0.25 8,000,000 3.98 $ - $ 0.1160 500,000 3.27 $ - $ 0.12 12,500,000 4.80 $ - $ 0.14 4,285,714 4.80 $ - For the year ended December 31, 2021, the following warrants were outstanding: Exercise Price Warrants Weighted Average Aggregate $ 0.001 11,000,000 3.07 $ 913,900 $ 0.056 1,000,000 3.52 $ 27,900 $ 0.04 2,300,000 4.75 $ 100,970 $ 0.06 7,398,639 0.18 $ 176,827 $ 0.08 3,699,320 0.18 $ 14,427 $ 0.08 3,699,320 1.18 $ 14,427 $ 0.2299 8,250,000 3.21 $ - $ 0.16 3,125,000 4.95 $ - $ 0.25 8,000,000 4.23 $ - $ 0.1160 500,000 3.52 $ - For the three months ended March 31, 2022, the following options were outstanding: SCHEDULE OF OPTIONS OUTSTANDING Weighted Average Exercise Options Options Remaining Price Outstanding Exercisable Contractual Life $ 0.115 - 26,802,500 18.870 For the year ended December 31, 2021, the following options were outstanding: Weighted Average Exercise Options Options Remaining Price Outstanding Exercisable Contractual Life $ 0.115 - 26,802,500 19.11 (D) Amendment to Articles of Incorporation On February 16, 2009, the Company amended its articles of incorporation to amend the number and class of shares the Company is authorized to issue as follows: ● Common stock Class A, unlimited ● Common stock Class B, unlimited ● Preferred stock, unlimited Effective December 17, 2013, the Company amended its articles of incorporation to designate a Series A no par value preferred stock. Two shares of Series A Preferred stock have been authorized. (E) Common Stock Issued for Debt On January 21, 2022, the Company issued 3,935,417 250,000 2,260 On January 31, 2022, the Company issued 4,569,059 250,000 42,877 On February 16, 2022, the Company issued 3,924,443 250,000 1,164

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 9 COMMITMENTS AND CONTINGENCIES On November 10, 2010, the Company entered into an employment agreement with its CEO, effective January 1, 2011 through the December 31, 2015. The term of the agreement is a five year period 210,000 6 281,027 20 5 297,889 5 315,764 5 422,561 2,999,143 2,991,191 On January 20, 2015, the board of directors appointed Mr. Jonathan R. Rice as our Chief Operating Officer. Mr. Rice’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to an annual cash compensation of $ 120,000 11,000 three-year 2,000,000 0.001 three 3,000,000 0.001 May 28, 2022 121,448 140,000 three 6,000,000 0.001 May 20, 2026 the Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the January 2015 warrant to January 10, 2025 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019. On March 25, 2019, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2020. On March 5, 2021, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2022. On February 25, 2022, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2023. 6,000,000 0.2299 20,000 20,000 20,000 As of March 31, 2022 and December 31, 2021, the Company owes $ 6,391 3,195 On July 3, 2019, the board of directors appointed Mr. Kenneth Le as the Company’s Director of Government relations and President of Prodigy Textiles. Mr. Le’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Le is entitled to annual cash compensation of $ 60,000 three 2,000,000 0.2299 2,130 1,065 (A) License Agreement On May 8, 2006, the Company entered into a license agreement. Pursuant to the terms of the agreement, the Company paid a non- refundable license fee of $ 10,000 10,000 13,700 10,000 On October 28, 2011, the Company entered into a license agreement with the University of Notre Dame. Under the agreement, the Company received exclusive and non-exclusive rights to certain spider silk technologies including commercial rights with the right to sublicense such intellectual property. In consideration of the licenses granted under the agreement, the Company agreed to issue to the University of Notre Dame 2,200,000 2 20 The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $ 5,000 4 265,244 4,025,652 281,659 20,000 On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with Mr. Thompson, its CEO. In accordance with FASB ASC No 480, Distinguishing Liabilities from Equity, 120,000 65,292 489 (B) Operating Lease Agreements Since September of 2015, we rent office space at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104, which is our principal place of business. We pay an annual rent of $ 2,508 On May 9, 2019, the Company signed a 5 4,560.57 45,150 On July 1, 2021, the Company signed a 5 6,000 8,645 On January 23, 2017 the Company signed an 8 960 3,683 6,263 On September 13, 2017, the Company signed a new two year lease with a 2 year option commencing on October 1, 2017 and ending on September 31, 2019. The Company paid an annual rent of $ 39,200 42,000 two-year lease 42,000 44,800 42,000 44,800

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 10 RELATED PARTY TRANSACTIONS On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with Mr. Thompson, its CEO. Pursuant to the addendum, the Company agreed to issue either 200,000 voting rights equal to 100 common shares per share of preferred stock 120,000 Distinguishing Liabilities from Equity 120,000 65,292 7 489 On November 10, 2010, the Company entered into an employment agreement, with its CEO, effective January 1, 2011 through the December 31, 2015. Subsequently, on January 1, 2018 the agreement renewed with the same terms for another 5 422,561 2,999,143 2,991,191 On January 14, 2016, the Company signed a new employment agreement with Mr. Rice, the Company’s COO. The employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to annual cash compensation of $ 140,000 three 6,000,000 0.001 the Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 10, 2025 for Mr. Rice. 20,000 20,000 20,000 As of March 31, 2022 and December 31, 2021, the Company owes $ 6,391 3,195 On July 3, 2019, the board of directors appointed Mr. Kenneth Le as the Company’s Director of Government relations and President of Prodigy Textiles. Mr. Le’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Le is entitled to an annual cash compensation of $ 60,000 three 2,000,000 0.2299 2,130 1,065 June 6, 2016, the Company received a $ 50,000 30,000 100,000 15,000 20,000 15,000 15,000 20,000 26,000 11,000 20,000 3,000 30,000 30,000 20,000 20,000 17,000 100,000 100,000 100,000 100,000 100,000 100,000 150,000 100,000 100,000 100,000 30,000 30,000 35,000 70,000 3 On January 26, 2022, the Company repaid $ 40,000 Total loan payable to principal stockholder for as of March 31, 2022 is $ 1,617,000 Total loan payable to this principal stockholder as of December 31, 2021 is $ 1,657,000 During the three months ended March 31, 2022, the Company recorded $ 18,385 13,610 During the three months ended March 31, 2021, the Company recorded $ 20,429 13,283 On January 23, 2017, the Company signed an 8 960 0 3,273 As of March 31, 2022 and December 31, 2021, there was $ 348,474 347,156 As of March 31, 2022 there was $ 1,787,736 149,518 As of December 31, 2021, there was $ 1,703,019 135,908 As of March 31, 2022, the Company owes $ 2,999,143 6,391 2,130 29,483 As of December 31, 2021, the Company owes $ 2,991,191 3,195 1,065 24,048 The Company owes $ 65,292

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11 SUBSEQUENT EVENTS The Company has analyzed its operations subsequent to May 6, 2022 through the date these financial statements were issued, and has determined that, other than disclosed below, it does not have any material subsequent events to disclose. On April 14, 2022, the Company issued 2,358,380 150,000 1,644 On April 29, 2022, the Company issued 4,373,417 250,000 5,918

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Policies)	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	(A) Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in The United States of America and the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations. It is management’s opinion, however that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. On March 5, 2018, the Company issued a board resolution authorizing investment in a Vietnamese subsidiary and appointing a representative for the subsidiary. On April 24, 2018, the Company announced that it had received its investment registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. On May 1, 2018, the Company announced that it had received its enterprise registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd
Foreign Currency	Foreign Currency The assets and liabilities of Prodigy Textiles, Co., Ltd. (the Company’s Vietnamese subsidiary) whose functional currency is the Vietnamese Dong, are translated into US dollars at period-end exchange rates prior to consolidation. Income and expense items are translated at the average rates of exchange prevailing during the period. The adjustments resulting from translating the Company’s financial statements are reflected as a component of other comprehensive (loss) income. Foreign currency transaction gains and losses are recognized in net earnings based on differences between foreign exchange rates on the transaction date and settlement date.
Use of Estimates	Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.
Cash	Cash For the purposes of the cash flow statements, the Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. There were no
Loss Per Share	Loss Per Share Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by the Financial Accounting Standards Board (“FASB” Accounting Standards Codification (“ASC”) No. 260, “Earnings per Share.” For March 31, 2022 and December 31, 2021, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive. The computation of basic and diluted loss per share for March 31, 2022 and 2021 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE March 31, 2022 December 31, 2021 Stock Warrants 54,660,034 48,972,277 Stock Warrants (Exercise price - $ 0.001 0.25 54,660,034 48,972,277 Stock Options (Exercise price - $ 0.1150 26,802,500 26,802,500 Convertible Debt 22,507,890 6,470,674 Convertible Preferred Stock 2 2 Total 103,970,426 82,245,453
Research and Development Costs	Research and Development Costs The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation.
Income Taxes	Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC No. 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC No. 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (“ASC 718”). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee’s requisite service period (generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed consolidated statements of operations. The Company accounts for stock-based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Changes to accounting principles are established by the FASB in the form of ASU’s to the FASB’s Codification. We consider the applicability and impact of all ASU’s on our financial position, results of operations, stockholders’ deficit, cash flows, or presentation thereof. Management has evaluated all recent accounting pronouncements as issued by the FASB in the form of Accounting Standards Updates (“ASU”) through the date these financial statements were available to be issued and found no recent accounting pronouncements issued, but not yet effective accounting pronouncements, when adopted, will have a material impact on the financial statements of the Company. In September 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Measurement of Credit Losses on Financial Instruments, which supersedes current guidance by requiring recognition of credit losses when it is probable that a loss has been incurred. The new standard requires the establishment of an allowance for estimated credit losses on financial assets including trade and other receivables at each reporting date. The new standard will result in earlier recognition of allowances for losses on trade and other receivables and other contractual rights to receive cash. In November 2019, the FASB issued ASU No. 2019-10, Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842), which extends the effective date of Topic 326 for certain companies until fiscal years beginning after December 15, 2022. The new standard will be effective for the Company in the first quarter of fiscal year beginning January 1, 2023, and early adoption is permitted. We adopted this pronouncement on January 1, 2021; however, the adoption of this standard did not have a material effect on the Company’s financial statements. In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes.” This guidance, among other provisions, eliminates certain exceptions to existing guidance related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also requires an entity to reflect the effect of an enacted change in tax laws or rates in its effective income tax rate in the first interim period that includes the enactment date of the new legislation, aligning the timing of recognition of the effects from enacted tax law changes on the effective income tax rate with the effects on deferred income tax assets and liabilities. Under existing guidance, an entity recognizes the effects of the enacted tax law change on the effective income tax rate in the period that includes the effective date of the tax law. ASU 2019-12 is effective for interim and annual periods beginning after December 15, 2020, with early adoption permitted. We adopted this pronouncement on January 1, 2021; however, the adoption of this standard did not have a material effect on the Company’s financial statements. However, based on the Company’s history of immaterial credit losses from trade receivables, management does not expect that the adoption of this standard will have a material effect on the Company’s financial statements. In August 2020, FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”), as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component, unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium. As a result, after adopting the guidance, entities will no longer separately present such embedded conversion features in equity and will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current accounting treatment under the current guidance. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the fiscal year. The Company adopted the guidance under ASU 2020-06 on January 1, 2022. The adoption of this guidance and had no material impact on the Company’s financial statements.
Equipment	Equipment The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. In accordance with FASB ASC No. 360, Property, Plant and Equipment, There were no
Fair Value of Financial Instruments	Fair Value of Financial Instruments We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” The three levels of the fair value hierarchy under ASC Topic 820-10 are described below: ● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at March 31, 2022 and 2021. ● Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. ● Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms. SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS March 31, 2022 December 31, 2021 Level 1 – Investment in Gold $ 460,163 $ 437,212 Level 2 $ - $ - Level 3 $ - $ - Total $ 460,163 $ 437,212 The Board of Directors, who serves as the Custodian, is responsible for the safekeeping of gold bullion owned by the Company. Fair value of the gold bullion held by the Company is based on that day’s London Bullion Market Association (“LBMA”) Gold Price PM. “LBMA Gold Price PM” is the price per fine troy ounce of gold, stated in U.S. dollars, determined by ICE Benchmark Administration (“IBA”) following an electronic auction consisting of one or more 30-second rounds starting at 3:00 p.m. (London time), on each day that the London gold market is open for business and published shortly thereafter. The following tables summarize activity in gold bullion for the quarter ended March 31, 2022: SCHEDULE OF GOLD IN BULLION Quarter Ended March 31, 2022 Ounces Cost Fair Value Balance December 31, 2021 239 $ 1,884 $ 437,212 Net change in unrealized gain - - 22,951 Ending balance 239 $ 1,884 $ 460,163
Revenue Recognition	Revenue Recognition Effective January 1, 2018, the Company adopted ASC No. 606 — Revenue from Contracts with Customers. Under ASC No. 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the three months ended March 31, 2022 and 2021, the Company recognized $ 0 0
Concentration of Credit Risk	Concentration of Credit Risk The Company at times has cash in banks in excess of FDIC insurance limits. At March 31, 2022 and December 31, 2021, the Company had approximately $ 3,362,681 2,092,420
Original Issue Discount	Original Issue Discount For certain notes issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded as a debt discount, reducing the face amount of the note, and is amortized to amortization of original issue discount in the consolidated statements of operations over the life of the debt.
Debt Issue Cost	Debt Issue Cost Debt issuance cost paid to lenders, or third parties are recorded as debt discounts and amortized to interest expense in the consolidated statements of operations, over the life of the underlying debt instrument.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Tables)	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE	The computation of basic and diluted loss per share for March 31, 2022 and 2021 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE March 31, 2022 December 31, 2021 Stock Warrants 54,660,034 48,972,277 Stock Warrants (Exercise price - $ 0.001 0.25 54,660,034 48,972,277 Stock Options (Exercise price - $ 0.1150 26,802,500 26,802,500 Convertible Debt 22,507,890 6,470,674 Convertible Preferred Stock 2 2 Total 103,970,426 82,245,453
SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS	SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS March 31, 2022 December 31, 2021 Level 1 – Investment in Gold $ 460,163 $ 437,212 Level 2 $ - $ - Level 3 $ - $ - Total $ 460,163 $ 437,212
SCHEDULE OF GOLD IN BULLION	The following tables summarize activity in gold bullion for the quarter ended March 31, 2022: SCHEDULE OF GOLD IN BULLION Quarter Ended March 31, 2022 Ounces Cost Fair Value Balance December 31, 2021 239 $ 1,884 $ 437,212 Net change in unrealized gain - - 22,951 Ending balance 239 $ 1,884 $ 460,163

EQUIPMENT (Tables)

EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY AND EQUIPMENT	At March 31, 2022 and December 31, 2021, property and equipment, net, is as follows: SCHEDULE OF PROPERTY AND EQUIPMENT March 31, 2022 December 31, 2021 Automobile $ 41,805 $ 41,805 Laboratory Equipment 118,890 118,890 Office Equipment 7,260 7,260 Leasehold Improvements 82,739 82,739 Property and equipment, gross Less: Accumulated Depreciation (147,201 ) (139,751 ) Total Property and Equipment, net $ 103,493 $ 110,943

RIGHT TO USE ASSETS AND LEASE_2

RIGHT TO USE ASSETS AND LEASE LIABILITITY (Tables)	3 Months Ended
	Mar. 31, 2022
Right To Use Assets And Lease Liabilitity
SCHEDULE OF RIGHT USE OF ASSETS	Right to use assets is summarized below: SCHEDULE OF RIGHT USE OF ASSETS March 31, 2022 Right to use assets, net 61,057 Right to use assets, net 32,074 Total $ 93,132
SCHEDULE OF LEASE LIABILITY	Lease liability is summarized below: SCHEDULE OF LEASE LIABILITY March 31, 2022 Operating lease liability, net 61,757 Operating lease liability, net 32,074 Total 93,831 Less: short term portion (46,178 ) Long term position $ 47,653
SCHEDULE OF LEASE COST	Lease expense for the three months ended March 31, 2022 was comprised of the following: SCHEDULE OF LEASE COST Operating lease expense $ 11,477 Operating lease expense $ 2,161

CONVERTIBLE NOTES (Tables)

CONVERTIBLE NOTES (Tables)	3 Months Ended
	Mar. 31, 2022
Convertible Notes
SCHEDULE OF FAIR VALUE WARRANTS	SCHEDULE OF FAIR VALUE WARRANTS Stock Price $ 0.14 Exercise price $ 0.16 Expected term (in years) 5 Expected volatility 60.64 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.10 % Stock Price $ 0.15 Exercise price $ 0.25 Expected term (in years) 5 Expected volatility 100.76 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.07 % Stock Price $ 0.08 Exercise price $ 0.12 Exercise price $ 0.14 Expected term (in years) 5 Expected volatility 124.10 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.58 %
SUMMARY OF CONVERTIBLE DEBT	The following represents a summary of the Company’s convertible debt at March 31, 2022: SUMMARY OF CONVERTIBLE DEBT Convertible Note Payable Amounts In-Default Balance – December 31, 2021 $ 503,423 $ Proceeds – net 1,500,000 - Debt discount and issue costs recorded (750,003 ) - Conversion of debt into common shares (750,000 ) Amortization of debt discount 362,032 - Balance – March 31, 2022 $ 865,452 $ - Accrued Interest Payable Amounts In-Default Balance – December 31, 2021 $ 31,657 $ Interest Expense March 31, 2022 45,180 - Interest conversion into common shares (46,301 ) Balance – March 31, 2022 $ 30,537 $ -

STOCKHOLDERS_ DEFICIT (Tables)

STOCKHOLDERS’ DEFICIT (Tables)	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
SCHEDULE OF OPTION ASSUMPTION	SCHEDULE OF OPTION ASSUMPTION Expected dividends 0 % Expected volatility 133.22 % Expected term 7 Risk free interest rate 1.46 % Expected forfeitures 0 % Expected dividends 0 % Expected volatility 125.19 % Expected term 3 Risk free interest rate 1.50 % Expected forfeitures 0 % Expected dividends 0 % Expected volatility 125.19 % Expected term 6 Risk free interest rate 1.46 % Expected forfeitures 0 %
SCHEDULE OF WARRANTS ACTIVITY	SCHEDULE OF WARRANTS ACTIVITY Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in Years) Balance, December 31, 2021 48,972,279 - 2.64 Granted 16,785,714      - Exercised (11,097,959 ) - - Cancelled/Forfeited - - - Balance, March 31, 2022 54,660,032 - 3.63 Intrinsic Value $ 1,166,993
SCHEDULE OF WARRANTS OUTSTANDING	For the three months ended March 31, 2022, the following warrants were outstanding: SCHEDULE OF WARRANTS OUTSTANDING Exercise Price Warrants Weighted Average Aggregate $ 0.001 11,000,000 2.82 $ 981,000 $ 0.056 1,000,000 3.27 $ 34,000 $ 0.04 2,300,000 4.51 $ 115,000 $ 0.08 3,699,320 0.94 $ 36,993 $ 0.2299 8,250,000 2.96 $ - $ 0.16 3,125,000 3.70 $ - $ 0.25 8,000,000 3.98 $ - $ 0.1160 500,000 3.27 $ - $ 0.12 12,500,000 4.80 $ - $ 0.14 4,285,714 4.80 $ - For the year ended December 31, 2021, the following warrants were outstanding: Exercise Price Warrants Weighted Average Aggregate $ 0.001 11,000,000 3.07 $ 913,900 $ 0.056 1,000,000 3.52 $ 27,900 $ 0.04 2,300,000 4.75 $ 100,970 $ 0.06 7,398,639 0.18 $ 176,827 $ 0.08 3,699,320 0.18 $ 14,427 $ 0.08 3,699,320 1.18 $ 14,427 $ 0.2299 8,250,000 3.21 $ - $ 0.16 3,125,000 4.95 $ - $ 0.25 8,000,000 4.23 $ - $ 0.1160 500,000 3.52 $ -
SCHEDULE OF OPTIONS OUTSTANDING	For the three months ended March 31, 2022, the following options were outstanding: SCHEDULE OF OPTIONS OUTSTANDING Weighted Average Exercise Options Options Remaining Price Outstanding Exercisable Contractual Life $ 0.115 - 26,802,500 18.870 For the year ended December 31, 2021, the following options were outstanding: Weighted Average Exercise Options Options Remaining Price Outstanding Exercisable Contractual Life $ 0.115 - 26,802,500 19.11

SCHEDULE OF ANTIDILUTIVE SECURI

SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Convertible preferred stock	103,970,426	82,245,453
Stock Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Convertible preferred stock	54,660,034	48,972,277
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Convertible preferred stock	26,802,500	26,802,500
Convertible Debt [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Convertible preferred stock	22,507,890	6,470,674
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Convertible preferred stock	2	2

SCHEDULE OF ANTIDILUTIVE SECU_2

SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE (Details) (Parenthetical)	Mar. 31, 2022$ / shares
Warrant exercise price per share	$ 0.06
Option exercise price	0.1150
Minimum [Member]
Warrant exercise price per share	0.001
Maximum [Member]
Warrant exercise price per share	$ 0.25

SCHEDULE OF FAIR VALUE OF FINAN

SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Fair value of assets and liabilities	$ 460,163	$ 437,212
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of assets and liabilities	460,163	437,212
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of assets and liabilities
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of assets and liabilities

SCHEDULE OF GOLD IN BULLION (De

SCHEDULE OF GOLD IN BULLION (Details)	3 Months Ended
	Mar. 31, 2022USD ($)oz	Mar. 31, 2021USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Beginning balance, ounce | oz	239
Beginning balance cost	$ 1,884
Beginning balalnce, fair value	$ 437,212
Net change in unrealized depreciation, ounce | oz
Net change in unrealized depreciation, cost
Net change in unrealized depreciation, fair value	$ 22,951
Ending balance, ounce | oz	239
Ending balance, cost	$ 1,884
Ending balance, fair value	$ 460,163

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash equivalents	$ 0		$ 0
Impairment losses on equipment	0	$ 0
Revenue
Cash excess of FDIC insurance limits	$ 3,362,681		$ 2,092,420

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital deficit	$ 4,651,491
Stockholders' Equity Attributable to Parent	4,101,460	$ 6,876,767	$ 5,295,875	$ 6,573,564
Net Cash Provided by (Used in) Operating Activities	$ 479,319	$ 418,653

SCHEDULE OF PROPERTY AND EQUIPM

SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Less: Accumulated Depreciation	$ (147,201)	$ (139,751)
Total Property and Equipment, net	103,493	110,943
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	41,805	41,805
Laboratory Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	118,890	118,890
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	7,260	7,260
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 82,739	$ 82,739

EQUIPMENT (Details Narrative)

EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 7,450	$ 6,668

SCHEDULE OF RIGHT USE OF ASSETS

SCHEDULE OF RIGHT USE OF ASSETS (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Jul. 02, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total	$ 93,132	$ 104,124	$ 241,800
Right To Use Assets Net [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total	61,057
Right to Use Assets Net One [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total	$ 32,074

SCHEDULE OF LEASE LIABILITY (De

SCHEDULE OF LEASE LIABILITY (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total	$ 93,831
Less: short term portion	(46,178)	$ (44,577)
Long term position	47,653	$ 59,897
Operating Lease Liability Net [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total	61,757
Operating Lease Liability Net One [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total	$ 32,074

SCHEDULE OF LEASE COST (Details

SCHEDULE OF LEASE COST (Details)	3 Months Ended
	Mar. 31, 2022USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Operating lease expense	$ 13,638
OperatingLeaseExpenses [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Operating lease expense	11,477
Operating Lease Expenses One [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Operating lease expense	$ 2,161

RIGHT TO USE ASSETS AND LEASE_3

RIGHT TO USE ASSETS AND LEASE LIABILITITY (Details Narrative)	Jul. 02, 2021USD ($)m²	May 09, 2019USD ($)m²	Jan. 23, 2017USD ($)	Mar. 31, 2022USD ($)	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)	Apr. 05, 2021USD ($)	Sep. 05, 2019USD ($)ft²	Sep. 13, 2017USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Rent payments			$ 960	$ 0	$ 3,683
Lease liabilities				46,178		$ 44,577
Operating lease, right-of-use asset	$ 241,800			93,132		$ 104,124
Lease term								2 years
Area of land | ft²								5,000
Annual rent, year one								$ 42,000	$ 39,200
Annual rent, year two								$ 44,800	$ 42,000
Lease expenses				13,638
Socialist Republic Of Vietnam [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lease term	5 years	5 years
Area of land | m²	6,000	4,560.57
Annual rent, year one	$ 8,645	$ 45,150
Annual rent, year two		$ 45,150
Rent increase percentage		5.00%
Operating Lease Agreements [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Rent payments				2,508
Operating Lease Agreements [Member] | Socialist Republic Of Vietnam [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Rent payments	$ 8,645
Area of land | m²	6,000	4,560.57
Annual rent, year one		$ 45,150
Annual rent, year two		$ 45,150
Operating Lease Agreements [Member] | October 1, 2022 through September 30, 2023 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Rent payments				44,800
Operating Lease Agreements [Member] | Office and Manufacturing Space [Member] | July 1, 2021 and ending on September 30, 2022 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Rent payments				42,000
Removal Of New Guidance [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lease liabilities							$ 44,419
Operating lease, right-of-use asset							$ 44,419
Adoption Of New Guidance [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lease liabilities				79,862
Operating lease, right-of-use asset				$ 79,862

ACCRUED INTEREST _ RELATED PA_2

ACCRUED INTEREST – RELATED PARTY (Details Narrative) - USD ($)	Dec. 01, 2020	Nov. 17, 2020	Nov. 04, 2020	Oct. 19, 2020	Sep. 10, 2020	Aug. 12, 2020	Jul. 16, 2020	Jun. 03, 2020	Apr. 08, 2020	Mar. 09, 2020	Jan. 24, 2020	Dec. 18, 2019	Nov. 20, 2019	Mar. 01, 2019	Feb. 19, 2019	Feb. 15, 2019	Feb. 01, 2019	Jan. 17, 2019	Jan. 04, 2019	Dec. 21, 2018	Oct. 12, 2018	Oct. 01, 2018	Jul. 05, 2018	Jun. 29, 2018	Jun. 21, 2018	Apr. 26, 2018	Mar. 31, 2018	Jan. 08, 2018	Dec. 01, 2017	Jun. 06, 2016	Mar. 31, 2022	Mar. 31, 2021	Jan. 26, 2022	Dec. 31, 2021	Dec. 31, 2020
Short-Term Debt [Line Items]
Proceeds from debt	$ 70,000	$ 35,000	$ 30,000	$ 30,000	$ 100,000	$ 100,000	$ 100,000	$ 150,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000	$ 20,000	$ 100,000	$ 20,000	$ 30,000	$ 30,000	$ 3,000	$ 20,000	$ 11,000	$ 26,000	$ 20,000	$ 15,000	$ 15,000	$ 20,000	$ 15,000	$ 100,000	$ 30,000	$ 50,000
Debt Instrument, Interest rate																																			3.00%
Notes payable, related parties, current																															$ 1,617,000		$ 40,000	$ 1,657,000
Paid-in-kind interest																															18,385	$ 20,429
Interest payable																															$ 13,610	$ 13,283
Loan One [Member]
Short-Term Debt [Line Items]
Proceeds from debt																			$ 17,000

NOTE PAYABLE (Details Narrative

NOTE PAYABLE (Details Narrative) - USD ($)	Jan. 26, 2022	Mar. 31, 2022	Mar. 31, 2021	Jul. 08, 2021	Dec. 31, 2020	Mar. 01, 2019
Short-Term Debt [Line Items]
Notes payable		$ 115,244		$ 180,244
Debt instrument, interest rate debt instrument, interest rate					3.00%
Repayment of debt	$ 40,000	20,000	$ 10,000
First Six Months [Member]
Short-Term Debt [Line Items]
Repayment of debt		1,000
Seven and Eight Months [Member]
Short-Term Debt [Line Items]
Repayment of debt		2,000
Nine Through Twenty Three Months [Member]
Short-Term Debt [Line Items]
Repayment of debt		5,000
24th Month [Member]
Short-Term Debt [Line Items]
Notes payable		180,224
13 Months [Member]
Short-Term Debt [Line Items]
Repayment of debt		5,000
14 Months [Member]
Short-Term Debt [Line Items]
Repayment of debt		57,622
20 Months [Member]
Short-Term Debt [Line Items]
Repayment of debt		57,622
Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Repayment of debt		$ 20,000
Notre Dame [Member] | Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Notes payable						$ 265,244
Debt instrument, interest rate debt instrument, interest rate						10.00%

SCHEDULE OF FAIR VALUE WARRANTS

SCHEDULE OF FAIR VALUE WARRANTS (Details)	Jan. 18, 2022$ / shares	Mar. 25, 2021$ / shares	Dec. 11, 2020$ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants term		5 years	5 years
Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.08	0.15	0.14
Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage		0.25	0.16
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants term	5 years	5 years	5 years
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	124.10	100.76	60.64
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0	0	0
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.58	0.07	0.10

SUMMARY OF CONVERTIBLE DEBT (De

SUMMARY OF CONVERTIBLE DEBT (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Short-Term Debt [Line Items]
Balance, beginning	$ 503,423
Proceeds - net	1,490,000	$ 450,000
Balance, ending	865,452
Balance, beginning	31,657
Balance, Accrued interest In-Default
Interest expense	45,180
Interest conversion into common shares	(46,301)
Balance, ending	30,537
Balance, Accrued interest In-Default
Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Balance, beginning	503,423
Balance, In-Default
Proceeds - net	1,500,000
Debt discount and issue costs recorded	(750,003)
Conversion of debt into common shares	(750,000)
Amortization of debt discount	362,032
Balance, ending	865,452
Balance, In-Default

CONVERTIBLE NOTES (Details Narr

CONVERTIBLE NOTES (Details Narrative)	Feb. 16, 2022USD ($)shares	Jan. 31, 2022USD ($)shares	Jan. 21, 2022USD ($)shares	Jan. 18, 2022USD ($)$ / shares	Apr. 22, 2021USD ($)	Apr. 06, 2021USD ($)	Mar. 25, 2021USD ($)$ / sharesshares	Dec. 11, 2020USD ($)$ / sharesshares	Mar. 31, 2022USD ($)$ / sharesshares	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)$ / shares	Dec. 31, 2020
Debt instrument, interest rate												3.00%
Debt instrument, discount									$ 634,548		$ 246,577
Proceeds from convertible note payable, net of original issue discount									1,490,000	$ 450,000
Number of warrants issued | shares							8,000,000	3,125,000
Warrants term							5 years	5 years
Fair value of warrants				$ 1,071,437			$ 3,359,716	$ 2,599,066
Debt issuance costs									$ 625,003
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares									$ 0.06
Class of warrant issued | shares									16,785,714
Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares									$ 0.001
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares									0.25
Common Stock [Member]
Common shares issued for debt conversion, shares	$ 250,000	$ 250,000	$ 250,000
Debt Conversion, Converted Instrument, Shares Issued | shares	3,924,443	4,569,059	3,935,417
Debt Instrument, Increase, Accrued Interest	$ 1,164	$ 42,877	$ 2,260
Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares									$ 0.001		$ 0.001
Measurement Input, Share Price [Member]
Warrants, measurement input, percentage | $ / shares				0.08			0.15	0.14
Measurement Input, Exercise Price [Member]
Warrants, measurement input, percentage | $ / shares							0.25	0.16
Measurement Input, Exercise Price [Member] | Minimum [Member]
Warrants, measurement input, percentage | $ / shares				0.12
Measurement Input, Exercise Price [Member] | Maximum [Member]
Warrants, measurement input, percentage | $ / shares				0.14
Measurement Input, Expected Term [Member]
Warrants term				5 years			5 years	5 years
Measurement Input, Price Volatility [Member]
Warrants, measurement input, percentage				124.10			100.76	60.64
Measurement Input, Expected Dividend Rate [Member]
Warrants, measurement input, percentage				0			0	0
Measurement Input, Risk Free Interest Rate [Member]
Warrants, measurement input, percentage				0.58			0.07	0.10
Unsecured Convertible Note [Member]
Issuance of convertible securities				$ 1,500,000				$ 1,000,000	$ 1,500,000
Debt instrument, interest rate				10.00%				10.00%
Percentage of original issue discount								5.00%
Debt instrument, discount				$ 10,000				$ 50,000
Proceeds from convertible note payable, net of original issue discount				$ 1,490,000				$ 950,000
Debt instrument, description				The note contains a discount to market feature, whereby, the lender can purchase stock at 85% of the lowest trading price for a period of ten (10) days preceding the conversion date				The note contains a discount to market feature, whereby, the lender can purchase stock at 90% of the lowest trading price for a period of ten (10) days preceding the conversion date
Number of warrants issued | shares									12,000,000
Warrants term									5 years
Debt issuance costs				$ 115,000			$ 330,000	$ 86,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares									$ 0.12
Unsecured Convertible Note [Member] | Warrant [Member]
Number of warrants issued | shares									4,285,714
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares									$ 0.14
Unsecured Convertible Note [Member] | First Convertible Debenture [Member]
Debt instrument, interest rate							10.00%
Debt instrument, discount							$ 3,670,000	$ 1,000,000
Debt instrument, description							The note contains a discount to market feature, whereby, the lender can purchase stock at 80% of the lowest trading price for a period of ten (10) days preceding the conversion date
Debt face amount							$ 4,000,000
Common shares issued for debt conversion, shares							$ 500,000
Debt instrument, maturity date							Mar. 25, 2022
Unsecured Convertible Note [Member] | Secound Convertible Debenture [Member]
Common shares issued for debt conversion, shares						$ 500,000
Unsecured Convertible Note [Member] | Third Convertible Debenture [Member]
Common shares issued for debt conversion, shares					$ 3,000,000

SCHEDULE OF OPTION ASSUMPTION (

SCHEDULE OF OPTION ASSUMPTION (Details)	3 Months Ended
	Mar. 31, 2022
Common Stock Warrants and Options [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividends	0.00%
Expected volatility	133.22%
Expected term	7 years
Risk free interest rate	1.46%
Expected forfeitures	0.00%
Common stock warrants and option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividends	0.00%
Expected volatility	125.19%
Expected term	3 years
Risk free interest rate	1.50%
Expected forfeitures	0.00%
Common stock warrants and option one [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividends	0.00%
Expected volatility	125.19%
Expected term	6 years
Risk free interest rate	1.46%
Expected forfeitures	0.00%

SCHEDULE OF WARRANTS ACTIVITY (

SCHEDULE OF WARRANTS ACTIVITY (Details)	3 Months Ended
	Mar. 31, 2022USD ($)$ / sharesshares
Equity [Abstract]
Number of warrants, intrinsic value	48,972,279
Weighted average exercise price, beginning balance | $ / shares
Weighted average remaining contractual life (In Years), ending balance	2 years 7 months 20 days
Number of warrants, granted	16,785,714
Weighted average exercise price, granted | $ / shares
Number of warrants, exercised	(11,097,959)
Weighted average exercise price, cancelled/forfeited | $ / shares
Number of warrants, cancelled/forfeited
Number of warrants, ending balance	54,660,032
Weighted average exercise price, ending balance | $ / shares
Weighted average remaining contractual life (In Years), ending balance	3 years 7 months 17 days
Number of warrants, intrinsic value | $	$ 1,166,993

SCHEDULE OF WARRANTS OUTSTANDIN

SCHEDULE OF WARRANTS OUTSTANDING (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price warrants outstanding	$ 0.06
Aggregate intrinsic value	$ 1,166,993
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price warrants outstanding	$ 0.001	$ 0.001
Warrants exercisable	11,000,000	11,000,000
Weighted average remaining contractual life	2 years 9 months 25 days	3 years 25 days
Aggregate intrinsic value	$ 981,000	$ 913,900
Warrant One [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price warrants outstanding	$ 0.056	$ 0.056
Warrants exercisable	1,000,000	1,000,000
Weighted average remaining contractual life	3 years 3 months 7 days	3 years 6 months 7 days
Aggregate intrinsic value	$ 34,000	$ 27,900
Warrant Two [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price warrants outstanding	$ 0.04	$ 0.04
Warrants exercisable	2,300,000	2,300,000
Weighted average remaining contractual life	4 years 6 months 3 days	4 years 9 months
Aggregate intrinsic value	$ 115,000	$ 100,970
Warrant Three [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price warrants outstanding	$ 0.08	$ 0.06
Warrants exercisable	3,699,320	7,398,639
Weighted average remaining contractual life	11 months 8 days	2 months 4 days
Aggregate intrinsic value	$ 36,993	$ 176,827
Warrant Four [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price warrants outstanding	$ 0.2299	$ 0.08
Warrants exercisable	8,250,000	3,699,320
Weighted average remaining contractual life	2 years 11 months 15 days	2 months 4 days
Aggregate intrinsic value		$ 14,427
Warrant Five [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price warrants outstanding	$ 0.16	$ 0.08
Warrants exercisable	3,125,000	3,699,320
Weighted average remaining contractual life	3 years 8 months 12 days	1 year 2 months 4 days
Aggregate intrinsic value		$ 14,427
Warrant Six [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price warrants outstanding	$ 0.25	$ 0.2299
Warrants exercisable	8,000,000	8,250,000
Weighted average remaining contractual life	3 years 11 months 23 days	3 years 2 months 15 days
Aggregate intrinsic value
Warrant Seven [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price warrants outstanding	$ 0.1160	$ 0.16
Warrants exercisable	500,000	3,125,000
Weighted average remaining contractual life	3 years 3 months 7 days	4 years 11 months 12 days
Aggregate intrinsic value
Warrant Eight [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price warrants outstanding	$ 0.12	$ 0.25
Warrants exercisable	12,500,000	8,000,000
Weighted average remaining contractual life	4 years 9 months 18 days	4 years 2 months 23 days
Aggregate intrinsic value
Warrant Nine [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price warrants outstanding	$ 0.14	$ 0.1160
Warrants exercisable	4,285,714	500,000
Weighted average remaining contractual life	4 years 9 months 18 days	3 years 6 months 7 days
Aggregate intrinsic value

SCHEDULE OF OPTIONS OUTSTANDING

SCHEDULE OF OPTIONS OUTSTANDING (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Equity [Abstract]
Exercise price	$ 0.115	$ 0.115
Options Outstanding
Options exercisable	26,802,500	26,802,500
Weighted average remaining contractual life	18 years 10 months 13 days	19 years 1 month 9 days

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)

Feb. 16, 2022

Feb. 15, 2022

Jan. 31, 2022

Jan. 21, 2022

Jan. 25, 2021

Feb. 19, 2020

Mar. 09, 2019

Feb. 16, 2009

Mar. 31, 2022

Dec. 31, 2021

Jun. 24, 2021

Mar. 02, 2021

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of shares issued

7,398,639

Warrants to purchase up share

16,785,714

Warrant exercise price per share

$ 0.06

Issuance of common stock in connection with warrant exercise

7,398,639

Stock issued during period, value

$ 443,918

Options to purchase shares

2,500,000

Preferred stock, shares authorized

Unlimited

Unlimited

Unlimited

Common Class A [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Common stock, shares authorized

Unlimited

Unlimited

Unlimited

Common Class B [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Common stock, shares authorized

Unlimited

Unlimited

Unlimited

Warrant [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

$ 0.001

$ 0.001

Issuance of common stock in connection with warrant exercise

3,699,320

Stock issued during period, value

$ 295,946

Warrant One [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

0.056

0.056

Warrant Two [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

0.04

0.04

Warrant Three [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

0.08

0.06

Warrant Four [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

$ 0.2299

$ 0.08

Common Stock [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of shares issued

3,699,320

Debt conversion, converted instrument, shares issued

3,924,443

4,569,059

3,935,417

Debt conversion, converted instrument, amount

$ 250,000

$ 250,000

$ 250,000

Debt instrument, increase, accrued interest

$ 1,164

$ 42,877

$ 2,260

Common Stock Warrants and Options [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Share price

$ 0.134

$ 0.115

Fair value of options

$ 310,165

$ 626,047

Common stock warrants and option F [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Common stock warrants and options, description

Options vest 33.3% on the year one anniversary of the grant date, 33.3% will vest on the second anniversary, and 33.3% will vest on the third year anniversary as long as the employee remains with the Company at the end of each successive year for three years

Common stock warrants and option [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Options to purchase shares

6,000,000

Share based compensation, expense

$ 27,989

Options description

Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030

Common Stock Warrants And Option Seven [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Share based compensation, expense

25,710

Common stock warrants and option one [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Share price

$ 0.115

Options to purchase shares

1,340,000

Fair value of options

$ 133,063

Share based compensation, expense

$ 7,842

Options description

Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027

Purchase Agreement [Member] | Warrant [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrants to purchase up share

1,479,728

Warrant exercise price per share

$ 0.06

$ 0.06

Warrant expiration date

Mar. 8, 2021

Mar. 8, 2021

Purchase Agreement [Member] | Warrant One [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrants to purchase up share

1,479,728

Warrant exercise price per share

$ 0.06

$ 0.06

Warrant expiration date

Mar. 8, 2022

May 8, 2021

Purchase Agreement [Member] | Warrant Two [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrants to purchase up share

1,479,728

Warrant exercise price per share

$ 0.08

$ 0.06

Warrant expiration date

Mar. 8, 2022

Dec. 8, 2021

Jul. 8, 2021

Purchase Agreement [Member] | Warrant Three [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrants to purchase up share

1,479,728

Warrant exercise price per share

$ 0.08

$ 0.06

Warrant expiration date

Mar. 8, 2023

Sep. 8, 2021

Purchase Agreement [Member] | Warrant Four [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrants to purchase up share

1,479,727

Warrant exercise price per share

$ 0.06

Warrant expiration date

Nov. 8, 2021

Purchase Agreement [Member] | Investor [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of shares issued

14,797,278

Share price

$ 0.06758

Proceeds from issuance of common stock

$ 1,000,000

Purchase Agreement [Member] | Investor [Member] | Class A Common Stock and Two Warrants [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of shares issued

14,797,278

Purchase Agreement [Member] | Investor [Member] | Six Cent Warrant [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrants to purchase up share

14,797,278

Warrant exercise price per share

$ 0.06

Purchase Agreement [Member] | Investor [Member] | Eight Cent Warrant [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrants to purchase up share

7,398,639

Warrant exercise price per share

$ 0.08

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative)

Feb. 15, 2022USD ($)shares

Jan. 26, 2022USD ($)

Jul. 02, 2021USD ($)m²

Sep. 05, 2019USD ($)ft²

Aug. 15, 2019USD ($)

Jul. 03, 2019USD ($)$ / sharesshares

May 09, 2019USD ($)m²

Apr. 26, 2019USD ($)

Mar. 01, 2019USD ($)shares

Jan. 09, 2018

Jan. 23, 2017USD ($)

Jan. 14, 2016USD ($)$ / sharesshares

Jan. 20, 2015USD ($)$ / sharesshares

Oct. 28, 2011USD ($)shares

Nov. 10, 2010USD ($)

Dec. 26, 2006USD ($)shares

May 08, 2006USD ($)

Jan. 31, 2007USD ($)

Mar. 31, 2022USD ($)$ / shares

Mar. 31, 2021USD ($)

Dec. 31, 2022USD ($)

Dec. 31, 2021USD ($)

Dec. 31, 2020USD ($)

Dec. 31, 2019

Dec. 31, 2017USD ($)

Dec. 31, 2016USD ($)

Dec. 31, 2015USD ($)

Mar. 25, 2021

Dec. 11, 2020

Aug. 08, 2019$ / sharesshares

Sep. 13, 2017USD ($)

May 28, 2015$ / sharesshares

Loss Contingencies [Line Items]

Annual salary

$ 184,808

$ 159,898

Accrued salary balance

$ 2,999,143

2,991,191

Warrants term

5 years

5 years

Warrant exercise price per share | $ / shares

$ 0.06

Number of shares issued | shares

7,398,639

Payment for debt

$ 40,000

$ 20,000

10,000

Stock issued during period, value

$ 443,918

Accrued Interest payable

30,537

$ 31,657

Payments for rent

$ 960

0

3,683

Area of land | ft²

5,000

Annual rent, year two

$ 44,800

$ 42,000

Annual rent, year one

$ 42,000

$ 39,200

Related Party [Member]

Loss Contingencies [Line Items]

Payments for rent

$ 0

$ 3,273

Socialist Republic Of Vietnam [Member]

Loss Contingencies [Line Items]

Area of land | m²

6,000

4,560.57

Annual rent, year two

$ 45,150

Annual rent, year one

$ 8,645

$ 45,150

Maximum [Member]

Loss Contingencies [Line Items]

Warrant exercise price per share | $ / shares

$ 0.25

Mr. Jonathan R. Rice [Member]

Loss Contingencies [Line Items]

Payroll payment

$ 6,391

3,195

Mr Rice [Member]

Loss Contingencies [Line Items]

Payroll payment

6,391

3,195

Mr. Kenneth Le [Member]

Loss Contingencies [Line Items]

Accrued salary balance

2,130

1,065

Board of Directors Chairman [Member]

Loss Contingencies [Line Items]

Accrued salary balance

2,130

1,065

Employment Agreement [Member]

Loss Contingencies [Line Items]

Extended expiration date description

the Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 10, 2025 for Mr. Rice.

Employment Agreement [Member] | Chief Executive Officer [Member]

Loss Contingencies [Line Items]

Agreement term description

The term of the agreement is a five year period

Annual salary

$ 210,000

$ 315,764

$ 297,889

$ 281,027

Annual salary rate, increase

6.00%

Agreement term

5 years

5 years

5 years

Employment Agreement [Member] | Chief Executive Officer [Member] | Subsequent Event [Member]

Loss Contingencies [Line Items]

Annual salary

$ 422,561

Employment Agreement [Member] | Employee [Member]

Loss Contingencies [Line Items]

Employee bonus rate

20.00%

Employment Agreement [Member] | Mr. Jonathan R. Rice [Member]

Loss Contingencies [Line Items]

Annual salary

$ 20,000

$ 20,000

Annual cash compensation

$ 140,000

$ 120,000

Educational expenses

$ 11,000

Warrants term

3 years

Warrant to purchase common stock shares | shares

6,000,000

6,000,000

Warrant exercise price per share | $ / shares

$ 0.001

$ 0.2299

Warrants maturity date

May 20, 2026

Warrants issued value

$ 121,448

Extended expiration date description

the Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the January 2015 warrant to January 10, 2025 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019. On March 25, 2019, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2020. On March 5, 2021, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2022. On February 25, 2022, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2023.

One-time bonus

$ 20,000

Employment Agreement [Member] | Mr. Jonathan R. Rice [Member] | January 2015 Warrant [Member]

Loss Contingencies [Line Items]

Warrants term

3 years

Warrant to purchase common stock shares | shares

2,000,000

Warrant exercise price per share | $ / shares

$ 0.001

Employment Agreement [Member] | Mr. Jonathan R. Rice [Member] | May 2015 Warrant [Member]

Loss Contingencies [Line Items]

Warrants term

3 years

Warrant to purchase common stock shares | shares

3,000,000

Warrant exercise price per share | $ / shares

$ 0.001

Warrants maturity date

May 28, 2022

Employment Agreement [Member] | Mr. Kenneth Le [Member]

Loss Contingencies [Line Items]

Annual cash compensation

$ 60,000

Warrants term

3 years

Warrant to purchase common stock shares | shares

2,000,000

Warrant exercise price per share | $ / shares

$ 0.2299

License Agreement [Member]

Loss Contingencies [Line Items]

Agreement term

20 years

License fee

$ 10,000

License maintenance fee

$ 10,000

Annual research fee

$ 13,700

Number of shares issued | shares

2,200,000

Royalty percentage

2.00%

Termination agreement description

The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $5,000 if the termination takes place within 2 years after its effectiveness, $10,000 if the termination takes place within 4 years after its effectiveness and $20,000 if the Agreement is terminated after 4 years.

License termination fee

$ 5,000

Payment for debt

20,000

License Agreement [Member] | Maximum [Member]

Loss Contingencies [Line Items]

Annual research fee

$ 10,000

License Agreement [Member] | Common Class A [Member]

Loss Contingencies [Line Items]

Number of shares issued | shares

4,025,652

Payment for debt

$ 265,244

Stock issued during period, value

$ 281,659

Consulting Agreement [Member]

Loss Contingencies [Line Items]

Warrants term

4 years

Royalty and Research Agreements [Member] | Mr. Thompson [Member]

Loss Contingencies [Line Items]

Payment for debt

$ 120,000

Intellectual Property Transfer Agreement [Member] | Mr. Thompson [Member]

Loss Contingencies [Line Items]

Number of shares issued | shares

200,000

Stock issued during period, value

$ 120,000

Outstanding balance

65,292

$ 65,292

Accrued Interest payable

489

Operating Lease Agreements [Member]

Loss Contingencies [Line Items]

Payments for rent

2,508

Operating lease, term

8 years

Operating lease term, description

two-year lease

Operating Lease Agreements [Member] | October 1, 2022 through September 30, 2023 [Member]

Loss Contingencies [Line Items]

Payments for rent

44,800

Operating Lease Agreements [Member] | Office and Manufacturing Space [Member] | July 1, 2021 and ending on September 30, 2022 [Member]

Loss Contingencies [Line Items]

Payments for rent

$ 42,000

Operating Lease Agreements [Member] | Related Party [Member]

Loss Contingencies [Line Items]

Payments for rent

$ 3,683

$ 6,263

Operating Lease Agreements [Member] | Monthly Rent [Member]

Loss Contingencies [Line Items]

Payments for rent

$ 960

Operating Lease Agreements [Member] | Socialist Republic Of Vietnam [Member]

Loss Contingencies [Line Items]

Payments for rent

$ 8,645

Operating lease description

the Company signed a 5 year property lease with the Socialist Republic of Vietnam which consists of 4,560.57 square meters of space, which it leases at a current rent of approximately $45,150 per year one and two and with the 5% increase per year for years three through five.

Operating lease, term

5 years

5 years

Area of land | m²

6,000

4,560.57

Annual rent, year two

$ 45,150

Annual rent, year one

$ 45,150

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Feb. 15, 2022	Jan. 26, 2022	Dec. 01, 2020	Nov. 17, 2020	Nov. 04, 2020	Oct. 19, 2020	Sep. 10, 2020	Aug. 12, 2020	Jul. 16, 2020	Jun. 03, 2020	Apr. 08, 2020	Mar. 09, 2020	Feb. 19, 2020	Jan. 24, 2020	Dec. 18, 2019	Nov. 20, 2019	Aug. 15, 2019	Jul. 03, 2019	Apr. 26, 2019	Mar. 01, 2019	Feb. 15, 2019	Feb. 01, 2019	Jan. 17, 2019	Jan. 04, 2019	Jan. 04, 2019	Dec. 21, 2018	Oct. 12, 2018	Oct. 01, 2018	Jul. 05, 2018	Jun. 29, 2018	Jun. 21, 2018	Apr. 26, 2018	Mar. 31, 2018	Jan. 09, 2018	Jan. 08, 2018	Dec. 02, 2017	Jan. 23, 2017	Jun. 06, 2016	Jan. 14, 2016	Jan. 20, 2015	Nov. 10, 2010	Dec. 26, 2006	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Mar. 25, 2021	Dec. 11, 2020	Aug. 08, 2019
Related Party Transaction [Line Items]
Number of shares issued	7,398,639
Stock issued during period, value	$ 443,918
Debt Instrument, Interest rate																																															3.00%
Accrued interest																																											$ 13,610	$ 13,283
Annual salary																																											184,808	159,898
Accrued salary balance																																											$ 2,999,143	2,991,191
Warrants term																																																			5 years	5 years
Warrant exercise price per share																																											$ 0.06
Repayment of debt		$ 40,000																																									$ 20,000	10,000
Loans payable amount		$ 40,000																																									1,617,000			$ 1,657,000
Paid-in-kind interest																																											18,385	20,429
Interest payable																																											13,610	13,283
Payments for rent																																					$ 960						0	3,683
Related Party [Member]
Related Party Transaction [Line Items]
Accrued interest																																											1,787,736			1,703,019
Payments for rent																																											0	$ 3,273
Loan interest - related party																																											149,518			135,908
Royalty payable to related party																																											65,292			65,292
Mr. Jonathan R. Rice [Member]
Related Party Transaction [Line Items]
Payroll payable																																											6,391			3,195
Mr. Kenneth Le [Member]
Related Party Transaction [Line Items]
Accrued salary balance																																											2,130			1,065
Stockholder [Member]
Related Party Transaction [Line Items]
Debt Instrument, Interest rate																																															3.00%
Loan received			$ 70,000	$ 35,000	$ 30,000	$ 30,000	$ 100,000	$ 100,000	$ 100,000	$ 150,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000				$ 20,000	$ 20,000	$ 30,000	$ 30,000	$ 3,000	$ 17,000	$ 20,000	$ 11,000	$ 26,000	$ 20,000	$ 15,000	$ 15,000	$ 20,000	$ 15,000		$ 100,000	$ 30,000		$ 50,000
Chief Executive Officer and Chief Operations Officer [Member]
Related Party Transaction [Line Items]
Accounts payable and accrued expenses																																											348,474			347,156
Principal Stockholder [Member]
Related Party Transaction [Line Items]
Accrued salary balance																																											2,999,143			2,991,191
Director and Employee [Member]
Related Party Transaction [Line Items]
Payroll payable																																											6,391			3,195
Chief Operating Officer [Member]
Related Party Transaction [Line Items]
Accrued salary balance																																											2,130			1,065
Office Employees [Member]
Related Party Transaction [Line Items]
Accrued salary balance																																											29,483			24,048
Intellectual Property Transfer Agreement [Member] | Mr. Thompson [Member]
Related Party Transaction [Line Items]
Number of shares issued																																										200,000
Preferred stock voting rights																																										voting rights equal to 100 common shares per share of preferred stock
Stock issued during period, value																																										$ 120,000
Outstanding balance																																														$ 65,292	$ 65,292
Debt Instrument, Interest rate																																														7.00%
Accrued interest																																											489
Employment Agreement [Member]
Related Party Transaction [Line Items]
Extended expiration date description																																		the Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 10, 2025 for Mr. Rice.
Employment Agreement [Member] | Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Annual salary																																									$ 210,000							$ 315,764	$ 297,889	$ 281,027
Employment Agreement [Member] | Chief Executive Officer [Member] | Forecast [Member]
Related Party Transaction [Line Items]
Annual salary																																													$ 422,561
Employment Agreement [Member] | Mr. Jonathan R. Rice [Member]
Related Party Transaction [Line Items]
Annual salary																	$ 20,000		$ 20,000
Annual cash compensation																																							$ 140,000	$ 120,000
Warrants term																																							3 years
Warrant to purchase shares																																							6,000,000														6,000,000
Warrant exercise price per share																																							$ 0.001														$ 0.2299
Extended expiration date description																																		the Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the January 2015 warrant to January 10, 2025 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019. On March 25, 2019, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2020. On March 5, 2021, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2022. On February 25, 2022, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2023.
One-time bonus																			$ 20,000
Employment Agreement [Member] | Mr. Kenneth Le [Member]
Related Party Transaction [Line Items]
Annual cash compensation																		$ 60,000
Warrants term																		3 years
Warrant to purchase shares																		2,000,000
Warrant exercise price per share																		$ 0.2299
Operating Lease Agreements [Member]
Related Party Transaction [Line Items]
Lessee, Operating Lease, Term of Contract																																					8 years
Payments for rent																																											$ 2,508
Operating Lease Agreements [Member] | Related Party [Member]
Related Party Transaction [Line Items]
Payments for rent																																														$ 3,683	$ 6,263
Operating Lease Agreements [Member] | President [Member]
Related Party Transaction [Line Items]
Payments for rent																																					$ 960

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Apr. 29, 2022	Apr. 14, 2022	Mar. 31, 2022	Mar. 31, 2021
Subsequent Event [Line Items]
Interest Payable			$ 13,610	$ 13,283
Subsequent Event [Member]
Subsequent Event [Line Items]
Debt conversion, converted instrument, shares issued	4,373,417	2,358,380
Debt conversion, converted instrument, amount	$ 250,000	$ 150,000
Interest Payable	$ 5,918	$ 1,644